1. Home
  2. BOLT vs CCTG Comparison

BOLT vs CCTG Comparison

Compare BOLT & CCTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • CCTG
  • Stock Information
  • Founded
  • BOLT 2015
  • CCTG 1993
  • Country
  • BOLT United States
  • CCTG Hong Kong
  • Employees
  • BOLT N/A
  • CCTG N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • CCTG
  • Sector
  • BOLT Health Care
  • CCTG
  • Exchange
  • BOLT Nasdaq
  • CCTG Nasdaq
  • Market Cap
  • BOLT 16.8M
  • CCTG 18.9M
  • IPO Year
  • BOLT 2021
  • CCTG 2024
  • Fundamental
  • Price
  • BOLT $0.40
  • CCTG $1.52
  • Analyst Decision
  • BOLT Hold
  • CCTG
  • Analyst Count
  • BOLT 5
  • CCTG 0
  • Target Price
  • BOLT $1.13
  • CCTG N/A
  • AVG Volume (30 Days)
  • BOLT 146.3K
  • CCTG 40.6K
  • Earning Date
  • BOLT 05-13-2025
  • CCTG 12-27-2024
  • Dividend Yield
  • BOLT N/A
  • CCTG N/A
  • EPS Growth
  • BOLT N/A
  • CCTG N/A
  • EPS
  • BOLT N/A
  • CCTG N/A
  • Revenue
  • BOLT $7,690,000.00
  • CCTG $16,463,490.00
  • Revenue This Year
  • BOLT N/A
  • CCTG N/A
  • Revenue Next Year
  • BOLT $77.45
  • CCTG N/A
  • P/E Ratio
  • BOLT N/A
  • CCTG N/A
  • Revenue Growth
  • BOLT N/A
  • CCTG 3.27
  • 52 Week Low
  • BOLT $0.38
  • CCTG $1.20
  • 52 Week High
  • BOLT $1.48
  • CCTG $3.41
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 40.42
  • CCTG 40.16
  • Support Level
  • BOLT $0.38
  • CCTG $1.50
  • Resistance Level
  • BOLT $0.47
  • CCTG $1.79
  • Average True Range (ATR)
  • BOLT 0.04
  • CCTG 0.16
  • MACD
  • BOLT -0.00
  • CCTG -0.01
  • Stochastic Oscillator
  • BOLT 18.81
  • CCTG 4.26

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.

Share on Social Networks: